Among patients with average life expectancies of less than 10 years, the proportion who underwent treatments such as surgery ...

In the active surveillance era, overtreatment of men with limited life expectancy (LE) decreased for those with low-risk ...

This trend runs counter to efforts promoting “active surveillance” of prostate cancers in men where treatment would ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

Clinicians must appropriately assess life expectancy and take steps to avoid prostate cancer overtreatment. Even in the active surveillance era, overtreatment persists among men with limited life ...

Increasing numbers of older U.S. men with prostate cancer are undergoing treatments that carry risks of side effects that can ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

The long-term rates of 10 prostate cancer surgery vs radiation side effects are high, which carries implications for decision-making.